We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Devices » Managing Data and Documentation for FDA Inspections and Remote Assessments
Managing-Data-and-Documentation-for-FDA-Inspections-and-Remote-Assessments-500.png

Managing Data and Documentation for FDA Inspections and Remote Assessments

$225.00
Device Products

Product Details

During a regulatory inspection, having quick and easy access to your most important documentation is essential for a positive outcome. With the FDA now looking at records electronically — either on site or remotely — the necessity of always being “inspection ready” has increased exponentially.

To increase your expertise on effective data and documentation processes, turn to this must-read report Managing Data and Documentation for FDA Inspections and Remote Assessments. With practical advice and insights from current and former FDA inspectors, you’ll learn how to optimize and organize your records for your next inspection while avoiding pitfalls in data retrieval, improper or missing documentation and electronic data transmission.

Key Takeaways: 

  • Understand the types of documents commonly requested during inspections and remote assessments.
  • Handle paper documents properly and provide investigators with access to electronic source data without compromising security.
  • Determine the “Top 10” questions to ask about your archival process.
  • Know the perils of emails as documentation and how to avoid them.
  • Recognize the difference between copies and originals and what FDA regulations require.

Arm yourself with the knowledge needed to ensure a successful FDA inspection or record review. Order Managing Data and Documentation for FDA Inspections and Remote Assessments today.

About the Contributors

David Chesney is the Principal and General Manager for DL Chesney Consulting, providing GMP and GCP compliance consulting and training services to clients worldwide. He served for more than 20 years as vice president, strategic compliance services for PAREXEL Consulting. Prior to joining PAREXEL, he served 23 years with the FDA as an investigator, supervisory investigator, Director of Investigations and as District Director in San Francisco, managing all FDA operations in Northern California, Nevada, and Hawaii.

This report also includes insights from Elizabeth Miller, FDA Assistant Commissioner for Medical Products and Tobacco Operations, and two former FDA investigators — Robert Darius, head of quality compliance at Sanofi Specialty Care, and William Mestrandrea, senior director of GMP/GDP auditing and inspection preparedness at Bristol Myers Squibb.

Who Will Benefit

  • QA/QC managers and staff
  • Document managers and staff
  • Regulatory affairs managers and staff
  • IT managers and staff
  • Lab managers and staff
  • Project coordinators
  • Principal investigators

PDF

$225.00
Add to Cart

Contributors:
David Chesney, Elizabeth Miller, Robert Darius and William Mestrandrea

ISBN:
978-1-60430-220-2

Publication date:
Sept. 2023

Page count:
66


Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Books Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing